Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223

Ersilia Nigro | Cardiovascular Researches | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Ersilia Nigro
Università della Campania Vanvitelli, Italy

Ersilia Nigro
Affiliation Università della Campania Vanvitelli
Country Italy
Scopus ID 57194323816
Documents 119
Citations 3,964
h-index 33
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-5637-1685

The Innovative Research Award recognizes the scholarly contributions of Ersilia Nigro, an Italian researcher affiliated with Università della Campania Vanvitelli, whose work has advanced knowledge in cardiovascular and metabolic sciences. Her interdisciplinary research explores adipokines, inflammatory biomarkers, exercise physiology, metabolic dysfunction, and lifestyle-related determinants of cardiovascular health. With an established publication record, a Scopus h-index of 33, and nearly four thousand citations, her investigations have contributed to translational approaches linking molecular mechanisms with clinical practice.[1]

Abstract

This article summarizes the scientific profile of Ersilia Nigro in relation to the Innovative Research Award. Her work integrates molecular cardiology, metabolism, and preventive medicine, emphasizing biomarkers associated with obesity, inflammation, exercise adaptation, and cardiovascular risk. Current research demonstrates sustained engagement with emerging topics including adiponectin signaling, orexin regulation, muscle wasting, and cardiometabolic interventions.[2]

Keywords

Cardiovascular research; adipokines; exercise physiology; obesity; inflammation; cardiometabolic health; translational medicine; biomarkers.

Introduction

Contemporary cardiovascular science increasingly relies on multidisciplinary investigations connecting lifestyle behaviors with molecular pathways. Nigro’s research addresses this need by examining how exercise, nutrition, sleep, and metabolic dysfunction influence cardiovascular outcomes and chronic disease progression.[3]

Research Profile

Her publication portfolio spans clinical, translational, and experimental studies. Indexed in Scopus with 119 documents and 3,964 citations, her scholarship demonstrates sustained influence across cardiovascular medicine, endocrinology, and metabolic research. Collaborative investigations frequently examine biomarker-driven approaches to patient stratification and disease management.[1]

Research Contributions

  • Investigation of adiponectin isoforms and inflammatory biomarkers in chronic diseases.
  • Evaluation of exercise interventions and their effects on cardiometabolic health.
  • Analysis of lifestyle factors, including sleep and nutrition, in cardiovascular regulation.
  • Research on muscle wasting, dyslipidemia, and patient management strategies in chronic respiratory disorders.

Publications

Recent publications include studies on irisin responses in obese middle-aged males, exercise-induced modulation of adiponectin, orexin and lifestyle habits, COPD-associated muscle wasting, and inflammatory markers in Crohn’s disease.[4]

Research Impact

The impact of Nigro’s work is reflected in extensive citation activity and the adoption of biomarker-based approaches within cardiometabolic research. Her studies support evidence-informed strategies for prevention, risk assessment, and personalized interventions targeting obesity-related cardiovascular conditions.[5]

Award Suitability

The Innovative Research Award acknowledges scientific originality, interdisciplinary collaboration, and measurable influence. Nigro’s sustained contributions across cardiovascular medicine, molecular biology, and preventive health align with these criteria through a record of peer-reviewed outputs, translational relevance, and international visibility.[6]

Conclusion

Ersilia Nigro has established a significant research profile at the intersection of cardiovascular science and metabolism. Her investigations continue to inform understanding of biomolecular pathways underlying cardiometabolic disorders while advancing preventive and therapeutic perspectives relevant to contemporary healthcare challenges.

References

  1. Elsevier. (n.d.). Scopus author details: Ersilia Nigro, Author ID 57194323816. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57194323816
  2. Nigro, E., et al. (2026). Effects of Two Different Training Programs on Cardiometabolic Health, Body Composition and Irisin in Middle Age Obese Males: A Pilot Study. Life.
    DOI: https://doi.org/10.3390/life16040657
  3. Nigro, E., et al. (2025). Orexin and Lifestyle Habits: A Meaningful Connection Among Nutrition, Physical Activity, and Sleep Pattern in Health and Diseases. International Journal of Molecular Sciences.
    DOI: https://doi.org/10.3390/ijms26188980
  4. Nigro, E., et al. (2026). Acute Resistance Exercise Temporarily Reduces Circulating Adiponectin in Trained Young Men: A Pilot Study. Biomolecules. DOI: https://doi.org/10.3390/biom16020229
  5. Nigro, E., et al. (2025). Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13081817
  6. Nigro, E., et al. (2025). Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13020273

Quan Yuan | Cardiovascular| Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Quan Yuan | Cardiovascular | Best Researcher Award 

Prof. QuanYuan, Wuhan University, China

Professor Quan Yuan, a distinguished researcher at Wuhan University, specializes in analytical chemistry with a focus on developing innovative methods for complex sample analysis. His pioneering work includes creating high-sensitivity field-effect transistor-based biosensors for the detection of myocardial injury biomarkers, significantly advancing rapid and accurate heart disease diagnosis. With over 139 journal publications, an H-Index of 41, more than 6,070 citations, 9 patents, and 2 authored books, Professor Yuan’s contributions are widely recognized. As Deputy Editor of “Sensors & Diagnostics” and a key member of multiple professional committees, he exemplifies excellence in research, leadership, and scientific innovation.

Author Profile

Orcid Profile

Education:

Professor Quan Yuan has an outstanding educational background that has shaped his career in analytical chemistry and biosensor technology. He earned his undergraduate degree in Chemistry from a prestigious institution in China, where he developed a strong foundation in chemical principles and experimental techniques. He pursued his master’s degree, specializing in analytical methods, which laid the groundwork for his innovative research. Professor Yuan completed his Ph.D. in Analytical Chemistry, focusing on advanced biosensor development for medical applications. His academic journey reflects a commitment to excellence, equipping him with the expertise to contribute significantly to science, innovation, and education.

Professional Experience:

Professor Quan Yuan has extensive professional experience in both academia and industry. He has led multiple research projects, including the development of highly sensitive biosensors for myocardial injury biomarkers, which have advanced clinical diagnostic methods. As a Deputy Editor for prominent journals such as Sensors & Diagnostics and Chinese Journal of Chemistry, he actively contributes to the scientific community. Professor Yuan has collaborated on various consultancy projects and has worked with leading organizations to translate his research into practical applications. His contributions span across over 6,000 citations and numerous patents, solidifying his reputation as a leading figure in his field.

Research skills:

Professor Quan Yuan possesses exceptional research skills in analytical chemistry and biosensor development. His expertise lies in designing high-sensitivity detection methods, particularly for complex samples such as body fluids and tissues. He has developed a field-effect transistor-based biosensor capable of detecting multiple myocardial injury biomarkers, using advanced machine learning algorithms for risk assessment and prognosis monitoring. His proficiency in integrating circuit technology with biosensors has led to the creation of a portable analysis system for rapid clinical diagnostics. Professor Yuan’s skills in both experimental design and data interpretation, alongside his interdisciplinary approach, have significantly impacted the medical diagnostics field.

Awards and Honors:

Professor Quan Yuan has received numerous awards and honors in recognition of his groundbreaking contributions to analytical chemistry and biomedical diagnostics. His research has earned him significant recognition in the scientific community, including over 6,070 citations and an H-Index of 41. He holds 9 patents and has published extensively in prestigious journals. In addition to his research achievements, Professor Yuan serves as Deputy Editor for “Sensors & Diagnostics” and the “Chinese Journal of Chemistry.” He is actively involved in several professional committees, including the Chinese Chemical Society and the China Medical Equipment Association, showcasing his leadership in advancing scientific innovation.

Conclusion:

Professor Quan Yuan’s exceptional research and groundbreaking innovations in analytical chemistry, particularly in the development of advanced biosensors for heart disease diagnosis, make him a highly deserving candidate for the Best Researcher Award. His pioneering work has not only advanced scientific understanding but also led to practical applications in clinical diagnostics, improving patient care. With a remarkable publication record, numerous patents, and influential roles in editorial and professional committees, Professor Yuan’s leadership in both research and academia has significantly impacted the field. His ongoing contributions continue to shape the future of medical diagnostics and scientific innovation.

Top Notable Publications

Persistent luminescence encoding for rapid and accurate oral-derived bacteria identification

Authors: Not provided

Journal: Chinese Chemical Letters

Year: 2025

Staggered-Stacking Two-Dimensional Covalent Organic Framework Membranes for Molecular and Ionic Sieving

Authors: Not provided

Journal: ACS Nano

Year: 2024

Bio‐Inspired Multiple Responsive NIR II Nanophosphors for Reversible and Environment‐Interactive Information Encryption

Authors: Not provided

Journal: Advanced Materials

Year: 2024

Framework nucleic acid strategy enables closer microbial contact for programming short-range interaction

Authors: Not provided

Journal: Science Advances

Year: 2024

Defect Regulation Strategy of Porous Persistent Phosphors for Multiple and Dynamic Information Encryption

Authors: Not provided

Journal: Small Methods

Year: 2024

DNA Nanomaterial-Based Electrochemical Biosensors for Clinical Diagnosis

Authors: Not provided

Journal: ACS Nano

Year: 2024

Smart Persistent Luminescence Imaging for Early Diagnosis of Drug-Induced Liver Injury

Authors: Not provided

Journal: Chemical & Biomedical Imaging

Year: 2024

Thermodynamics and Kinetics‐Directed Regulation of Nucleic Acid‐Based Molecular Recognition

Authors: Not provided

Journal: Small Methods

Year: 2024

Bionic Potassium Ion Channel in Live Cells Repairs Cardiomyocyte Function

Authors: Not provided

Journal: Journal of the American Chemical Society

Year: 2024

Self‐Powered and Self‐Recoverable Multimodal Force Sensors Based on Trap State and Interfacial Electron Transfer

Authors: Not provided

Journal: Angewandte Chemie International Edition / Angewandte Chemie

Year: 2024